SEC Info - Acro Biomedical Co., Ltd. - ‘10-Q’ for 6/30/22

SEC Info℠

Home

Help

Please Sign In

Acro Biomedical Co., Ltd. – ‘10-Q’ for 6/30/22 – ‘EX-101.CAL’

On: Friday, 8/12/22, at 4:17pm ET · For: 6/30/22 · Accession #: 1640334-22-1752 · File #: 0-55643

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/22  Acro Biomedical Co., Ltd.         10-Q        6/30/22   37:1.7M                                   Pubco Reporting … Inc/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    456K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     13K 
 9: R1          Cover                                               HTML     61K 
10: R2          Balance Sheets                                      HTML     99K 
11: R3          Balance Sheets (Parenthetical)                      HTML     30K 
12: R4          Statements of Operations (Unaudited)                HTML     74K 
13: R5          Statements of Changes in Stockholders' Equity       HTML     54K 
                (Unaudited)                                                      
14: R6          Statements of Cash Flows (Unaudited)                HTML     66K 
15: R7          Organization and Description of Business            HTML     18K 
16: R8          Summary of Significant Accounting Policies          HTML     25K 
17: R9          Going Concern                                       HTML     16K 
18: R10         Related Party Transactions                          HTML     16K 
19: R11         Leases                                              HTML     26K 
20: R12         Stockholders' Equity                                HTML     19K 
21: R13         Concentration                                       HTML     15K 
22: R14         Subsequent Events                                   HTML     15K 
23: R15         Summary of Significant Accounting Policies          HTML     39K 
                (Policies)                                                       
24: R16         Leases (Tables)                                     HTML     26K 
25: R17         Summary of Significant Accounting Policies          HTML     14K 
                (Details Narrative)                                              
26: R18         Related Party Transactions (Details Narrative)      HTML     27K 
27: R19         Leases (Details)                                    HTML     14K 
28: R20         Leases (Details 1)                                  HTML     18K 
29: R21         Leases (Details 2)                                  HTML     21K 
30: R22         Leases (Details Narrative)                          HTML     20K 
31: R23         Stockholders' Equity (Details Narrative)            HTML     33K 
32: R24         Concentration (Details Narrative)                   HTML     24K 
35: XML         IDEA XML File -- Filing Summary                      XML     58K 
33: XML         XBRL Instance -- acro_10q_htm                        XML    302K 
34: EXCEL       IDEA Workbook of Financial Reports                  XLSX     46K 
 6: EX-101.CAL  XBRL Calculations -- acro-20220630_cal               XML     80K 
 8: EX-101.DEF  XBRL Definitions -- acro-20220630_def                XML    112K 
 5: EX-101.LAB  XBRL Labels -- acro-20220630_lab                     XML    344K 
 7: EX-101.PRE  XBRL Presentations -- acro-20220630_pre              XML    253K 
 4: EX-101.SCH  XBRL Schema -- acro-20220630                         XSD     63K 
36: JSON        XBRL Instance as JSON Data -- MetaLinks              150±   201K 
37: ZIP         XBRL Zipped Folder -- 0001640334-22-001752-xbrl      Zip     85K

‘EX-101.CAL’ — XBRL Calculations — acro-20220630_cal

This Exhibit is an XBRL XML File.

<?xml version="1.0" standalone="yes" encoding="windows-1252"?>

<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://acro.com/role/Cover" xlink:href="acro-20220630.xsd#Cover" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/BalanceSheets" xlink:href="acro-20220630.xsd#BalanceSheets" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/BalanceSheetsParenthetical" xlink:href="acro-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/StatementsOfOperationsUnaudited" xlink:href="acro-20220630.xsd#StatementsOfOperationsUnaudited" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/StatementsOfChangesInStockholdersEquityUnaudited" xlink:href="acro-20220630.xsd#StatementsOfChangesInStockholdersEquityUnaudited" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/StatementsOfCashFlowsUnaudited" xlink:href="acro-20220630.xsd#StatementsOfCashFlowsUnaudited" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="acro-20220630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="acro-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/GoingConcern" xlink:href="acro-20220630.xsd#GoingConcern" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/RelatedPartyTransactions" xlink:href="acro-20220630.xsd#RelatedPartyTransactions" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/LEASES" xlink:href="acro-20220630.xsd#LEASES" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/StockholdersEquity" xlink:href="acro-20220630.xsd#StockholdersEquity" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/CONCENTRATION" xlink:href="acro-20220630.xsd#CONCENTRATION" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/SubsequentEvents" xlink:href="acro-20220630.xsd#SubsequentEvents" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="acro-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/LeasesTables" xlink:href="acro-20220630.xsd#LeasesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="acro-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="acro-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/LeasesDetails" xlink:href="acro-20220630.xsd#LeasesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/LeasesDetails1" xlink:href="acro-20220630.xsd#LeasesDetails1" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/LeasesDetails2" xlink:href="acro-20220630.xsd#LeasesDetails2" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/LeasesDetailsNarrative" xlink:href="acro-20220630.xsd#LeasesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/StockholdersEquityDetailsNarrative" xlink:href="acro-20220630.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://acro.com/role/ConcentrationDetailsNarrative" xlink:href="acro-20220630.xsd#ConcentrationDetailsNarrative" xlink:type="simple"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/BalanceSheets" xlink:title="000002 - Statement - Balance Sheets">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="acro-20220630.xsd#acro_PurchaseDepositForInventoryCurrent" xlink:label="loc_acroPurchaseDepositForInventoryCurrent"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_acroPurchaseDepositForInventoryCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset"/>

<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit"/>

<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>

<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent"/>

<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent"/>

<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent"/>

<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>

<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent"/>

<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>

<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>

<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>

<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="acro-20220630.xsd#acro_DeferredStockCompensationEquity" xlink:label="loc_acroDeferredStockCompensationEquity"/>

<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_acroDeferredStockCompensationEquity" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>

<link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>

<link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>

<link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/BalanceSheetsParenthetical" xlink:title="000003 - Statement - Balance Sheets (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/StatementsOfOperationsUnaudited" xlink:title="000004 - Statement - Statements of Operations (Unaudited)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseRelatedParty" xlink:label="loc_us-gaapInterestExpenseRelatedParty"/>

<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherExpenses" xlink:to="loc_us-gaapInterestExpenseRelatedParty" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>

<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>

<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit"/>

<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/StatementsOfChangesInStockholdersEquityUnaudited" xlink:title="000005 - Statement - Statements of Changes in Stockholders' Equity (Unaudited)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/StatementsOfCashFlowsUnaudited" xlink:title="000006 - Statement - Statements of Cash Flows (Unaudited)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="acro-20220630.xsd#acro_ChangeOfRouAndLeaseLiabilities" xlink:label="loc_acroChangeOfRouAndLeaseLiabilities"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_acroChangeOfRouAndLeaseLiabilities" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="acro-20220630.xsd#acro_ImputedInterestRelatedParties" xlink:label="loc_acroImputedInterestRelatedParties"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_acroImputedInterestRelatedParties" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>

<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions" xlink:label="loc_us-gaapAmortizationOfDeferredSalesCommissions"/>

<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDeferredSalesCommissions" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt"/>

<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt"/>

<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>

<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/GoingConcern" xlink:title="000009 - Disclosure - GOING CONCERN"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/RelatedPartyTransactions" xlink:title="000010 - Disclosure - RELATED PARTY TRANSACTIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/LEASES" xlink:title="000011 - Disclosure - LEASES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/StockholdersEquity" xlink:title="000012 - Disclosure - STOCKHOLDERS' EQUITY"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/CONCENTRATION" xlink:title="000013 - Disclosure - CONCENTRATION"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/SubsequentEvents" xlink:title="000014 - Disclosure - SUBSEQUENT EVENTS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/LeasesTables" xlink:title="000016 - Disclosure - LEASES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000018 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/LeasesDetails" xlink:title="000019 - Disclosure - LEASES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/LeasesDetails1" xlink:title="000020 - Disclosure - LEASES (Details 1)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/LeasesDetails2" xlink:title="000021 - Disclosure - LEASES (Details 2)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/LeasesDetailsNarrative" xlink:title="000022 - Disclosure - LEASES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/StockholdersEquityDetailsNarrative" xlink:title="000023 - Disclosure - STOCKHOLDERS' EQUITY (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://acro.com/role/ConcentrationDetailsNarrative" xlink:title="000024 - Disclosure - CONCENTRATION (Details Narrative)"/>

</link:linkbase>

↑Top

Filing Submission 0001640334-22-001752 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Acro Biomedical Co., Ltd. – ‘10-Q’ for 6/30/22 – ‘EX-101.CAL’

On: Friday, 8/12/22, at 4:17pm ET · For: 6/30/22 · Accession #: 1640334-22-1752 · File #: 0-55643

Previous ‘10-Q’: ‘10-Q’ on 5/16/22 for 3/31/22 · Next: ‘10-Q’ on 11/21/22 for 9/30/22 · Latest: ‘10-Q’ on 8/14/23 for 6/30/23

Quarterly Report — Form 10-QFiling Table of Contents

‘EX-101.CAL’ — XBRL Calculations — acro-20220630_cal

This Exhibit is an XBRL XML File.

Quarterly Report — Form 10-Q

Filing Table of Contents